☆ 4.4 Article

2-Aroyl quinazolinone: Synthesis and in vitro anti-parasitic activity

CHEMICAL BIOLOGY & DRUG DESIGN (2023)

Related references

Note: Only part of the references are listed.

Article Chemistry, Organic

Oxygen-Doped PAH Electrochromes: Difurano, Dipyrano, and Furano-Pyrano Containing Naphthalene-Cored Molecules

Jack Fletcher-Charles et al.

Summary: In this work, the synthesis of O-doped naphthalene-based electrochromes was reported using CuO-mediated Pummerer oxidative cycloetherification reaction. The spectroscopic profile strongly depends on the O-doping topology, with different electrochromic responses obtained based on O-topology and type of O-ring, featuring high contrasts involving yellow, pink, orange or blue colours. Computational investigations revealed the HOMO energy level changes and different electronic transitions of the synthesized derivatives.

EUROPEAN JOURNAL OF ORGANIC CHEMISTRY (2022)

Add to Collection

Review Public, Environmental & Occupational Health

Review of American Trypanosomiasis in Southern Mexico Highlights Opportunity for Surveillance Research to Advance Control Through the One Health Approach

Doireyner Daniel Velazquez-Ramirez et al.

FRONTIERS IN PUBLIC HEALTH (2022)

Add to Collection

Article Biochemical Research Methods

Updates on Prevalence and Trend Status of Visceral Leishmaniasis at Two Health Facilities in Amhara Regional State, Northwest Ethiopia: A Retrospective Study

Mulat Yimer et al.

Summary: This study aimed to report up-to-date information about visceral leishmaniasis in the Amhara Region of Ethiopia. Findings showed that daily laborers were the most affected individuals in the Metema areas. Among 2,703 suspected cases diagnosed with the rK39 test, 32.4% were confirmed positive cases.

BIOCHEMISTRY RESEARCH INTERNATIONAL (2022)

Add to Collection

Review Microbiology

Current Treatments to Control African Trypanosomiasis and One Health Perspective

Alberto Venturelli et al.

Summary: Human African Trypanosomiasis (HAT) and Animal African Trypanosomiasis (AAT) are tropical diseases caused by the same pathogen. Despite progress in controlling HAT, AAT remains a reservoir of infection. Clearer guidelines are needed to address the challenges of drug use and resistance development.

MICROORGANISMS (2022)

Add to Collection

Article Cardiac & Cardiovascular Systems

Global, Regional, and National Trends of Chagas Disease from 1990 to 2019: Comprehensive Analysis of the Global Burden of Disease Study

Sergio Alejandro Gomez-Ochoa et al.

Summary: The global burden of Chagas disease has changed in recent decades, with a sustained decline in the number of cases. While the majority of cases remain concentrated in Latin America, the increase observed in North America and Europe highlights the importance of screening and raising awareness among at-risk populations.

GLOBAL HEART (2022)

Add to Collection

Article Immunology

Impaired Th1 Response Is Associated With Therapeutic Failure in Patients With Cutaneous Leishmaniasis Caused by Leishmania braziliensis

Augusto M. Carvalho et al.

Summary: In patients with negative LST, there is a lower cure rate and impaired Th1 response, as well as an increased frequency of CD8(+) T cells and reduced inflammation in lesions. Restoration of Th1 response is associated with cure of the disease. Increased production of inflammatory cytokines, granzyme B, and MMP-9 contributes to immunopathology in LST-negative patients.

JOURNAL OF INFECTIOUS DISEASES (2021)

Add to Collection

Article Medicine, Research & Experimental

Advances in the treatment of Chagas disease: Promising new drugs, plants and targets

Paola Garcia-Huertas et al.

Summary: Chagas disease is currently treated with only two drugs, benznidazole and nifurtimox, which have limitations including efficacy in specific infection stages, adverse effects, and parasite resistance. Some institutions and research groups are exploring new therapeutic alternatives through strategies like dosage modification, drug repurposing, combined therapy, the study of medicinal plants, and identification of essential parasite genes for targeted drug design. Collaboration and knowledge exchange among these entities could lead to the development of innovative treatments for Chagas disease.

BIOMEDICINE & PHARMACOTHERAPY (2021)

Add to Collection

Article Chemistry, Medicinal

Synthesis and evaluation of 3′-fluorinated 7-deazapurine nucleosides as antikinetoplastid agents

Jakob Bouton et al.

Summary: Kinetoplastid parasites rely on purine salvage for their purine demand. Evaluating the effect of introducing a 3'-fluoro substituent in 7-deazapurine nucleosides, several analogs with potent anti-parasitic activity were discovered, showing that a fluorine atom in the 3'-position is a promising modification for the discovery of anti-parasitic nucleosides.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2021)

Add to Collection

Review Microbiology

Salivarian Trypanosomes Have Adopted Intricate Host-Pathogen Interaction Mechanisms That Ensure Survival in Plain Sight of the Adaptive Immune System

Stefan Magez et al.

Summary: Salivarian trypanosomes are extracellular parasites that affect humans, livestock, and game animals. While Trypanosoma brucei rhodesiense and Trypanosoma brucei gambiense cause human African trypanosomiasis, animal trypanosomiasis is not restricted to Africa and is present on all continents. Adapted to survive inside the host's immune system, these parasites have unique survival strategies that allow them to outsmart the immune system, hindering the development of effective anti-trypanosome vaccines for disease control.

PATHOGENS (2021)

Add to Collection

Article Chemistry, Organic

Synthesis and Biological Evaluation of 4′-Substituted Kaempfer-3-ols

Sugyeom Kim et al.

JOURNAL OF ORGANIC CHEMISTRY (2020)

Add to Collection

Article Medicine, General & Internal

Anti-Trypanosomal and Antimalarial Properties of Tetralone Derivatives and Structurally Related Benzocycloalkanones

Richard M. Beteck et al.

MEDICINA-LITHUANIA (2019)

Add to Collection

Review Immunology

Immunomodulatory Theraphy of Visceral Leishmaniasis in Human Immunodeficiency Virus-Coinfected Patients

Wim Adriaensen et al.

FRONTIERS IN IMMUNOLOGY (2018)

Add to Collection

Article Biochemistry & Molecular Biology

On-Water Synthesis of Quinazolinones and Dihydroquinazolinones Starting from o-Bromobenzonitrile

Zibin Liu et al.

MOLECULES (2018)

Add to Collection

Review Infectious Diseases

Leishmaniasis-HIV coinfection: current challenges

Jose Angelo Lauletta Lindoso et al.

HIV AIDS-RESEARCH AND PALLIATIVE CARE (2016)

Add to Collection

Review Infectious Diseases

Treatment options for second-stage gambiense human African trypanosomiasis

Gilles Eperon et al.

EXPERT REVIEW OF ANTI-INFECTIVE THERAPY (2014)

Add to Collection

Article Immunology

American Trypanosomiasis (Chagas Disease)

Anis Rassi et al.

INFECTIOUS DISEASE CLINICS OF NORTH AMERICA (2012)

Add to Collection

Article Immunology

Visceral Leishmaniasis

Johan van Griensven et al.

INFECTIOUS DISEASE CLINICS OF NORTH AMERICA (2012)

Add to Collection

Review Parasitology

Visceral leishmaniasis treatment: What do we have, what do we need and how to deliver it?

Lucio H. Freitas-Junior et al.

INTERNATIONAL JOURNAL FOR PARASITOLOGY-DRUGS AND DRUG RESISTANCE (2012)

Add to Collection

Article Immunology

Spread of vector-borne diseases and neglect of leishmaniasis, Europe

Jean-Claude Dujardin et al.

EMERGING INFECTIOUS DISEASES (2008)

Add to Collection

© Peeref 2019-2024. All rights reserved.